LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
23.84
-0.02 (-0.08%)
Feb 6, 2026, 4:00 PM EST - Market closed
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $602.62 million as of February 9, 2026.
Market Cap
602.62M
Enterprise Value
291.81M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.84
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $602.62M, an increase of 99.87%. That is a compound annual growth rate of 451.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 602.62M | 7.01% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 639.94M |
| enGene Holdings | 639.70M |
| SELLAS Life Sciences Group | 635.15M |
| Prime Medicine | 632.03M |
| Rigel Pharmaceuticals | 619.96M |
| Altimmune | 609.88M |
| Alpha Tau Medical | 606.23M |
| CorMedix | 605.89M |